Combination therapy of a type ii anti-cd20 antibody with an...

Details Combination therapy of a type ii anti-cd20 antibody with an... Combination therapy of a type ii anti-cd20 antibody with an...

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2702300

The present invention is directed to the use of a type II anti-CD20 antibody for the manufacture of a medicament for the treatment of cancer, especially of CD20 expressing cancers in combination with an anti-Bcl-2 active agent.

La présente invention a pour objet l'utilisation d'un anticorps anti-CD20 de type II pour la fabrication d'un médicament destiné au traitement du cancer, spécialement de cancers exprimant CD20 en association avec un agent actif anti-Bcl-2.

Affiliated with

Also associated with

Rating

Combination therapy of a type ii anti-cd20 antibody with an... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy of a type ii anti-cd20 antibody with an..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy of a type ii anti-cd20 antibody with an... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1425222